Practice
Featured experience
Emerson $7.2 billion acquisition of remaining outstanding shares of AspenTech
We are advising Emerson on its acquisition
Intra-Cellular Therapies $14.6 billion acquisition by Johnson & Johnson
We are advising Intra-Cellular Therapies on the transaction
GSK up to $1.15 billion acquisition of IDRx
We are advising GSK on the transaction
Royalty Pharma $1.1 billion acquisition of its external manager and $3 billion share repurchase
We are advising Royalty Pharma on the transaction
Teoxane proposal to acquire Revance Therapeutics
We are advising Teoxane on the proposed acquisition
Paychex $4.1 billion acquisition of Paycor HCM
We are advising Paychex on the transaction
American Savings Bank $405 million acquisition by an investor group
We advised American Savings Bank on the transactions
PineBridge Investments $1.2 billion acquisition by MetLife
We are advising PineBridge on the transaction
Prosus $1.7 billion acquisition of Despegar.com
We are advising Prosus on the acquisition
Elliott Investment Management acquires majority interest in American Greetings
We are advising Elliott on the transaction
Shyft Group merger with Aebi Schmidt Group
We are advising Shyft Group on the transaction
Comcast Business acquisition of Nitel from Cinven
We are advising Comcast Business on the acquisition
Nykredit cash tender offer for Spar Nord Bank
We are advising Nykredit on the tender offer
MoneyLion $1 billion acquisition by Gen Digital
We are advising MoneyLion on the acquisition